Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-17-001969
Filing Date
2017-03-24
Accepted
2017-03-24 12:18:01
Documents
7
Period of Report
2017-05-03
Effectiveness Date
2017-03-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2231431zdef14a.htm DEF 14A 445342
2 G429027.JPG g429027.jpg GRAPHIC 11523
3 G263414.JPG g263414.jpg GRAPHIC 5291
4 G725724.JPG g725724.jpg GRAPHIC 4803
5 G1016655.JPG g1016655.jpg GRAPHIC 6646
6 G10496BEI001.GIF g10496bei001.gif GRAPHIC 130758
7 G10496BEI002.GIF g10496bei002.gif GRAPHIC 80416
  Complete submission text file 0001047469-17-001969.txt   776979
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35024 | Film No.: 17711873
SIC: 2833 Medicinal Chemicals & Botanical Products